Stock FLHLF FILAMENT HEALTH CORP.
Add to a list
To use this feature you must be a member
Log inSign up

All News Filament Health Corp.

Equities

FLHLF

CA31685W1068

Delayed OTC Markets
Other stock markets
 07:17:13 25/06/2024 pm IST 		5-day change 1st Jan Change
0.0335 USD +0.15% Intraday chart for Filament Health Corp. +11.67% -38.08%
12/06 Filament Health Corp. announced that it has received CAD 1 million in funding from Negev Capital CI
03/06 Filament Health Announces Authorization of Phase 2 Clinical Trial for PEX010 in the Treatment of Methamphetamine Use Disorder CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Negev Capital Fund One, L.P. Reports Updated Holdings in Filament Health Corp.
NE
FILAMENT HEALTH ANNOUNCES CLOSING OF WARRANT EXERCISE, NOTE CONVERSION AND CONCURRENT PRIVATE PLACEMENT OF COMMON SHARES
AQ
Filament Health Corp. announced that it has received CAD 1 million in funding from Negev Capital
CI
FILAMENT HEALTH ANNOUNCES AUTHORIZATION OF PHASE 2 CLINICAL TRIAL FOR PEX010 IN THE TREATMENT OF METHAMPHETAMINE USE DISORDER
AQ
Filament Health Announces Authorization of Phase 2 Clinical Trial for PEX010 in the Treatment of Methamphetamine Use Disorder
CI
FILAMENT HEALTH ANNOUNCES WARRANT EXERCISE AND NOTE CONVERSION BY NEGEV CAPITAL AND CONCURRENT PRIVATE PLACEMENT OF COMMON SHARES TO BENJAMIN LIGHTBURN, CHIEF EXECUTIVE OFFICER
AQ
Filament Health Corp. announced that it expects to receive CAD 1 million in funding from Negev Capital and another investor
CI
FILAMENT HEALTH ANNOUNCES FIRST QUARTER 2024 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS
AQ
Filament Health Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
FILAMENT HEALTH ANNOUNCES CHANGE TO BOARD OF DIRECTORS
AQ
Filament Health Corp. Announces Change to Board of Directors
CI
FILAMENT HEALTH TO DISCUSS ITS DRUG DEVELOPMENT PLATFORM IN FIRESIDE CHAT WITH WATER TOWER RESEARCH ON APRIL 4, 2024 AT 12PM ET
AQ
FILAMENT HEALTH REPORTS Q4 AND YEAR END 2023 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS
AQ
Filament Health Corp. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
FILAMENT HEALTH ANNOUNCES APPOINTMENT OF MICHAEL MESSINGER TO ITS BOARD OF DIRECTORS
AQ
Filament Health Corp. Announces Appointment of Michael Messinger to Its Board of Directors and Chair of the Audit Committee
CI
Filament Health Corp. Announces Chief Financial Officer Changes
CI
FILAMENT HEALTH ANNOUNCES SHIPMENTS OF BOTANICAL PSILOCYBIN TO FOUR COUNTRIES FOR CLINICAL INVESTIGATION
AQ
Filament Health Corp. Announces Shipments of Botanical Psilocybin to Four Countries for Clinical Investigation
CI
FILAMENT HEALTH COMPLETES THE FIRST EXPORT OF BOTANICAL PSILOCYBIN TO ISRAEL
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. FLHLF Stock
  4. News Filament Health Corp.